We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Goldman Sachs (GS) Faces Criminal Charges Over 1MDB Case
Read MoreHide Full Article
The Goldman Sachs Group (GS - Free Report) and two of its former employees have been slapped with criminal charges by Malaysia in relation to the 1Malaysia Development Bhd (1MDB) scandal. However, the bank continues to deny any wrongdoing.
The Malaysian government seeks to charge a total penalty of more than $2.7 billion worth funds that were allegedly misused and the $600 million that Goldman had received as fees. Moreover, the two employees, if proven guilty, will have to serve prison terms of up to 10 years.
Goldman has been scrutinized for playing a part in raising funds through bond offerings for 1MDB — the fund, which is facing corruption and money-laundering probes in roughly six countries. Notably, per the U.S. Department of Justice, misappropriation of funds worth nearly $4.5 billion from 1MDB by top officials of the fund and their colleagues from 2009 through 2014 also included funds raised through Goldman.
Edward Naylor, Goldman’s Spokesman said, “We believe these charges are misdirected and we will vigorously defend them and look forward to the opportunity to present our case,”. He added, “The firm continues to cooperate with all authorities investigating these matters.”
In early December 2018, the Federal Reserve had speed up the investigation of the matter. Goldman’s representatives met with the central bank and defended the bank’s controls.
Goldman’s involvement in 1MDB scandal has taken a toll on its shares. The stock is down 28.7% in the past three months compared with the industry’s decline of 21.7%.
While the Federal Reserve is yet to disclose the sanctions that would be imposed on the bank, the matter is likely to have a significant effect on its financials. Also, other pending litigation issues remain a concern for the company.
Goldman currently carries a Zacks Rank #3 (Hold).
Stocks to Consider
Greenhill & Co., Inc. has witnessed 15.2% upward estimate revisions in the past 30 days. Moreover, this Zacks #1 Ranked (Strong Buy) stock has rallied more than 20% over the past year. You can see the complete list of today’s Zacks #1 Rank stocks here.
TD Ameritrade Holding Corporation (AMTD - Free Report) has been witnessing 2.8% upward estimate revisions in the past 30 days. Also, the company’s shares have gained nearly 9%, over the past two years. It carries a Zacks Rank of 2 (Buy), at present.
E*TRADE Financial Corporation has witnessed 3.5% upward estimate revisions over the past 30 days. Additionally, the company’s shares have gained nearly 24% over the past two years. It carries a Zacks Rank of 2, at present.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Image: Bigstock
Goldman Sachs (GS) Faces Criminal Charges Over 1MDB Case
The Goldman Sachs Group (GS - Free Report) and two of its former employees have been slapped with criminal charges by Malaysia in relation to the 1Malaysia Development Bhd (1MDB) scandal. However, the bank continues to deny any wrongdoing.
The Malaysian government seeks to charge a total penalty of more than $2.7 billion worth funds that were allegedly misused and the $600 million that Goldman had received as fees. Moreover, the two employees, if proven guilty, will have to serve prison terms of up to 10 years.
Goldman has been scrutinized for playing a part in raising funds through bond offerings for 1MDB — the fund, which is facing corruption and money-laundering probes in roughly six countries. Notably, per the U.S. Department of Justice, misappropriation of funds worth nearly $4.5 billion from 1MDB by top officials of the fund and their colleagues from 2009 through 2014 also included funds raised through Goldman.
Edward Naylor, Goldman’s Spokesman said, “We believe these charges are misdirected and we will vigorously defend them and look forward to the opportunity to present our case,”. He added, “The firm continues to cooperate with all authorities investigating these matters.”
In early December 2018, the Federal Reserve had speed up the investigation of the matter. Goldman’s representatives met with the central bank and defended the bank’s controls.
Goldman’s involvement in 1MDB scandal has taken a toll on its shares. The stock is down 28.7% in the past three months compared with the industry’s decline of 21.7%.
While the Federal Reserve is yet to disclose the sanctions that would be imposed on the bank, the matter is likely to have a significant effect on its financials. Also, other pending litigation issues remain a concern for the company.
Goldman currently carries a Zacks Rank #3 (Hold).
Stocks to Consider
Greenhill & Co., Inc. has witnessed 15.2% upward estimate revisions in the past 30 days. Moreover, this Zacks #1 Ranked (Strong Buy) stock has rallied more than 20% over the past year. You can see the complete list of today’s Zacks #1 Rank stocks here.
TD Ameritrade Holding Corporation (AMTD - Free Report) has been witnessing 2.8% upward estimate revisions in the past 30 days. Also, the company’s shares have gained nearly 9%, over the past two years. It carries a Zacks Rank of 2 (Buy), at present.
E*TRADE Financial Corporation has witnessed 3.5% upward estimate revisions over the past 30 days. Additionally, the company’s shares have gained nearly 24% over the past two years. It carries a Zacks Rank of 2, at present.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>